Immune System: Page 4

Oral cancer research points to an old enemy

By Dr. Alvin Danenberg

If we knew what was causing oral cancers, we might be able to treat it before it spreads, writes periodontist Dr. Alvin Danenberg. He looks at the research that suggests that Porphyromonas gingivalis, a bacteria very familiar to periodontists, may play a role in the spread of the most prevalent form of oral cancer.

November 21, 2017

Are periodontitis and rheumatoid arthritis linked?

By Dr. Alvin Danenberg

At first glance, periodontal disease and rheumatoid arthritis may not seem to have anything in common. However, periodontist Alvin Danenberg digs into the research and finds they may have more common ground than first thought.

September 12, 2017

Implants and inflammation

By Dr. Alvin Danenberg

Recent published research has raised a question about titanium dental implants and possible inflammation. Dr. Alvin Danenberg notes that while the vast majority of procedures using these implants have been successful and free of symptoms, he'd like to see well-designed studies undertaken and published so practitioners can offer their patients more complete information.

January 31, 2017

Can an anti-inflammatory diet improve periodontal health?

By Theresa Pablos

Switching to a diet focused on reducing inflammation may help those with periodontal disease, according to a small pilot study. Participants who reduced carbohydrates intake and increased consumption of omega-3 fatty acids showed a significant improvement in periodontal health.

August 9, 2016

New study examines antibody's link to Sjogren's

By DrBicuspid.com staff writers

Upcoming research from the University at Buffalo will study the possible link between IgM, a supposedly protective type of antibody, to Sjögren's syndrome and other autoimmune diseases.

January 14, 2016

MedImmune acquires rights to Inovio's HPV vaccine

By DrBicuspid.com staff writers

Inovio Pharmaceutial has entered into a license agreement with MedImmune for its INO-3112 immunotherapy for cancers caused by human papillomavirus (HPV) and also a collaboration to develop new cancer vaccines, the companies announced.

August 9, 2015

OncoSec enrolls 1st patient in immunotherapy clinical trial

By DrBicuspid.com staff writers

OncoSec Medical has enrolled the first patient in a phase II clinical trial that uses ImmunoPulse IL-12, an immunotherapy platform, to treat patients with squamous cell carcinoma of the head and neck.

June 17, 2015

Erectile dysfunction drug shows promise for HNSCC

By Donna Domino

The little yellow pills that have boosted men's sex lives for the past decade may someday fight head and neck cancers and other diseases, according to Florida researchers. The erectile dysfunction drug tadalafil, commonly known as Cialis, can modulate the body's immune system, resulting in a new therapeutic strategy for head and neck squamous cell carcinoma (HNSCC), a new trial has shown.

May 26, 2015

Study finds how T cells cause inflammation with oral candidiasis

By Donna Domino

Ohio dental researchers have found a method to study how T cells cause inflammation during oral candidiasis infections, according to a new study in the Journal of Visualized Experiments. The discovery can lead to new therapies or drugs that jump-start weakened or poorly functioning immune systems.

March 9, 2015

Japanese mushroom may help treat HPV infection

By DrBicuspid.com staff writers

A Japanese mushroom extract appears to be effective in eradicating human papillomavirus (HPV), according to a pilot clinical trial at the University of Texas Medical School at Houston

November 12, 2014

Study: Immune-related gene may predispose to HPV-related cancer

By DrBicuspid.com staff writers

An international coalition of cancer specialists has identified an immune-related gene called transforming growth factor beta receptor 1 (TGFBR1) that appears to play a pivotal role in determining whether a person develops HPV-related cancer. Their findings are discussed in the journal Cancer Research.

October 23, 2014

Study: Cancer prognosis related to newly identified immune cells

By DrBicuspid.com staff writers

A newly discovered type of immune cells in tumors is associated with less severe cancer outcomes in humans and may have therapeutic potential, according to a new study in the journal Cancer Cell. The better outcomes were especially strong in head and neck cancers and in breast cancers, the researchers found.

October 23, 2014

Previous Page

Page 4 of 7

Next Page